{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:56:32Z","timestamp":1761292592361},"reference-count":69,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2375,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1742-1241.2008.01979.x","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T20:38:22Z","timestamp":1233607102000},"page":"478-485","source":"Crossref","is-referenced-by-count":9,"title":["Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?"],"prefix":"10.1155","volume":"63","author":[{"given":"M.","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Berneis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Spinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. B.","family":"Rini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. K.","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB2","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1742-1241.2007.01571.x","article-title":"Quality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size","volume":"61","author":"Wierzbicki","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(90)90131-2","article-title":"Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation","volume":"83","author":"Griffin","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hci154","article-title":"Low-density-lipoproteins size and cardiovascular risk assessment","volume":"99","author":"Rizzo","year":"2006","journal-title":"QJM Int J Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB6","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1742-1241.2007.01507.x","article-title":"Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance","volume":"61","author":"Julius","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the longterm risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study","volume":"25","author":"St Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10557-006-8283-x","article-title":"The clinical relevance of low-density-lipoproteins size modulation by statins","volume":"20","author":"Rizzo","year":"2006","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF02848780","article-title":"Effects of statins, fibrates, rosuvastatin and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients","volume":"24","author":"Rizzo","year":"2007","journal-title":"Adv Ther"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0021-9150(95)05770-6","article-title":"Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system","volume":"123","author":"Bjornheden","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-2275(20)32551-7","article-title":"Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity","volume":"39","author":"Galeano","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0021-9150(85)90169-8","article-title":"Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content","volume":"55","author":"Camejo","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9343(00)00700-2","article-title":"Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins","volume":"110","author":"Tribble","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0021-9150(92)90255-F","article-title":"Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size","volume":"93","author":"Tribble","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.ATV.11.2.298","article-title":"Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects","volume":"11","author":"de Graaf","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB17","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocr Metab"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB18","first-page":"199","article-title":"The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects","volume":"25","author":"Lamarche","year":"1999","journal-title":"Diabetes Metab"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041433-200402000-00005","article-title":"Associations of low density lipoprotein particle composition with atherogenicity","volume":"15","author":"Lada","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.ATV.21.2.282","article-title":"Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia","volume":"21","author":"Guerin","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.ATV.0000107027.73816.ce","article-title":"Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits","volume":"24","author":"Rizzo","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"49","author":"El Harchaoui","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB24","doi-asserted-by":"crossref","first-page":"23K","DOI":"10.1016\/S0002-9149(03)00779-3","article-title":"Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams","volume":"92","author":"Brewer","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/mhj.2002.128049","article-title":"Effects of rosuvastatin and atorvastatin compared over 52\u2003weeks of treatment in patients with hypercholesterolemia","volume":"144","author":"Olsson","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9149(02)02994-6","article-title":"Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease","volume":"91","author":"Schneck","year":"2003","journal-title":"Am J Cardiol"},{"issue":"Suppl.","key":"10.1111\/j.1742-1241.2008.01979.x-BIB27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1368-504X.2004.00390.x","article-title":"A review of the efficacy of rosuvastatin in patients with type 2 diabetes","volume":"143","author":"Tuomilehto","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB28","first-page":"61A","article-title":"The rosuvastatin impact on ventricular remodelling cytokines and neurohormones (UNIVERSE) study [Abstract]","volume":"26","author":"Krum","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2005.09.008","article-title":"Statin use in heart failure - a cause for concern?","volume":"152","author":"Raina","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjcard.2005.08.026","article-title":"Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial","volume":"97","author":"Ferdinand","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB31","first-page":"349A","article-title":"Lipid-lowering results from the first large-scale trial of statin therap in Hispanic-American patients with hypercholesterolemia: STARSHIP [Abstract]","volume":"26","author":"Llorett","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl.","key":"10.1111\/j.1742-1241.2008.01979.x-BIB32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1567-5688(06)80631-8","article-title":"First large randomized trial of a statin therapy in South Asian patients at risk for coronary heart disease: the IRIS trial","volume":"206","author":"Deedwania","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1067\/mhj.2002.129312","article-title":"Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial","volume":"144","author":"Brown","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB35","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe0808320","article-title":"Expanding the orbit of primary prevention - moving beyond JUPITER","volume":"359","author":"Hlatky","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jclinepi.2007.07.016","article-title":"Early stopping of randomized trials for overt efficacy is problematic","volume":"61","author":"Bassler","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2003.08.025","article-title":"Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia","volume":"171","author":"Caslake","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.clinthera.2007.07.019","article-title":"A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia","volume":"29","author":"Kostapanos","year":"2007","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjcard.2007.08.035","article-title":"Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels","volume":"101","author":"Ai","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2008.06.007","article-title":"Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia","volume":"590","author":"Kostapanos","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.694","article-title":"Small, dense low-density-lipoproteins and the metabolic syndrome","volume":"23","author":"Rizzo","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","article-title":"Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System","volume":"47","author":"Hoefner","year":"2001","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB43","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1373\/clinchem.2005.059949","article-title":"Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics","volume":"52","author":"Ensign","year":"2006","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinchem\/38.1.150","article-title":"Measurement of low-density-lipoprotein cholesterol in serum: a status report","volume":"38","author":"Rifai","year":"1992","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB45","first-page":"27","article-title":"Multicenter evaluation of four homogenous LDL-cholesterol assays","volume":"63","author":"Bayer","year":"2005","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/clinchem\/48.2.236","article-title":"Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation","volume":"48","author":"Nauck","year":"2002","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB48","first-page":"IV","article-title":"LDL particle but not LDL cholesterol are highly elevated in the metabolic syndrome. Results from the Framingham Offspring Study","volume":"108","author":"Otvos","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2007.03.004","article-title":"Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome","volume":"197","author":"Ooi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1464-5491.2007.02095.x","article-title":"Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes","volume":"24","author":"Betteridge","year":"2007","journal-title":"Diabet Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ahj.2005.12.013","article-title":"vAchieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II","volume":"151","author":"Ballantyne","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjcard.2006.04.014","article-title":"Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial)","volume":"98","author":"Lloret","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1185\/030079906X112462","article-title":"Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)","volume":"22","author":"Milionis","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB54","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1185\/030079906X132721","article-title":"Lipid-altering efficacy of the ezetimibe\/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients","volume":"22","author":"Catapano","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2796.2005.01499.x","article-title":"Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study","volume":"257","author":"Wolffenbuttel","year":"2005","journal-title":"J Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.amjcard.2004.09.005","article-title":"Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia","volume":"95","author":"Lamendola","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB57","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.ahj.2004.01.020","article-title":"Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial","volume":"148","author":"Schwartz","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00019501-200403000-00008","article-title":"Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia","volume":"15","author":"Hunninghake","year":"2004","journal-title":"Coron Artery Dis"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB59","first-page":"48","article-title":"Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10\u2003mg with atorvastatin 10\u2003mg in adult patients with hypercholesterolaemia: the first Indian study","volume":"102","author":"Jayaram","year":"2004","journal-title":"J Indian Med Assoc"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.amjcard.2003.08.009","article-title":"Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia","volume":"92","author":"Stein","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB61","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0002-9149(03)00318-7","article-title":"Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels","volume":"91","author":"Capuzzi","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB62","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9149(01)02226-3","article-title":"Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia","volume":"89","author":"Davidson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB63","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0002-9149(01)01727-1","article-title":"Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia","volume":"88","author":"Olsson","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB64","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/CIRCULATIONAHA.105.555482","article-title":"The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis","volume":"111","author":"Alsheikh-Ali","year":"2005","journal-title":"Circulation."},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/pds.1281","article-title":"The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy","volume":"15","author":"McAfee","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB66","first-page":"73","article-title":"Rosuvastatin: an independent analysis of risks and benefits","volume":"8","author":"Zipes","year":"2006","journal-title":"Med Gen Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/pds.1278","article-title":"Results from a rosuvastatin historical cohort study in more than 45\u2003000 Dutch statin users, a PHARMO study.","volume":"15","author":"Goettsch","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB68","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01979.x-BIB69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.amjcard.2006.09.117","article-title":"Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins","volume":"99","author":"Asztalos","year":"2007","journal-title":"Am J Cardiol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01979.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01979.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:47Z","timestamp":1643349887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01979.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01979.x","relation":{},"ISSN":["1368-5031","1742-1241"],"issn-type":[{"value":"1368-5031","type":"print"},{"value":"1742-1241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}